Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitation.

COVID-19 low-T3 syndrome non-thyroidal-illness pulmonary rehabilitation thyroid

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 23 03 2023
accepted: 28 06 2023
medline: 2 8 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

Patients with severe COVID-19 often experience long-lasting disabilities that can improve after pulmonary rehabilitation. Moreover patients with severe COVID-19 display thyroid function alterations due to a non-thyroidal illness syndrome (NTIS). The aim of our study was to evaluate thyroid function parameters among patients hospitalized for COVID-19 who were eligible or not to respiratory rehabilitation and their modifications during follow-up. Post-COVID-19 patients referred to a Respiratory Rehabilitation Unit were evaluated. Outpatients, not candidate for rehabilitation, were enrolled as Control group. Patients who had completed a 4-week-rehabilitation program were enrolled as Rehabilitation Group. All patients were evaluated at T0 (4 weeks after the discharge home in Control Group and after completion of rehabilitation in Rehabilitation Group) and at T1 (3 months after T0). The final study group included 39 patients (20 in the Rehabilitation group and 19 in the Control group). Patients in the Rehabilitation Group had more frequently received invasive or non-invasive ventilation, had a longer length-of-stay in referring hospitals, had a higher number of comorbidities and displayed a worse performance at 6-minute-walking-test (6MWT) and Short-Physical-Performance-Battery-test (SPPB). FT3 values were lower at T0 in the Rehabilitation Group, while TSH and FT4 values were similar in the two groups. While no significant modifications in thyroid-function-parameters were observed in the Control Group, a significant increase in FT3 value was observed in the Rehabilitation Group at T1. Participants of both groups had improved the results of 6MWT at T1, while SPPB values improved only in the Rehabilitation Group. COVID-19 patients after pulmonary rehabilitation experience an increase in FT3 values during follow-up, paralleled with an amelioration of functional capabilities.

Identifiants

pubmed: 37522115
doi: 10.3389/fendo.2023.1192561
pmc: PMC10380937
doi:

Substances chimiques

Thyroxine Q51BO43MG4
Triiodothyronine 06LU7C9H1V
Thyroid Hormones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1192561

Informations de copyright

Copyright © 2023 Croce, Zampogna, Coperchini, Costa, Pignatti, Visca, Spanevello and Rotondi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1396
pubmed: 10764338
Expert Rev Respir Med. 2020 Dec;14(12):1249-1256
pubmed: 32799694
J Am Geriatr Soc. 1968 May;16(5):622-6
pubmed: 5646906
BMC Geriatr. 2019 Aug 8;19(1):216
pubmed: 31395008
Thyroid. 2021 Jan;31(1):8-11
pubmed: 32600165
Int J Chron Obstruct Pulmon Dis. 2015 Dec 03;10:2619-26
pubmed: 26664110
J Endocrinol Invest. 2021 May;44(5):891-904
pubmed: 33559848
J Endocrinol Invest. 2021 May;44(5):1031-1040
pubmed: 33140379
Respiration. 2021;100(5):416-422
pubmed: 33784696
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875
pubmed: 33892403
J Endocrinol Invest. 2021 May;44(5):1085-1090
pubmed: 33025553
Lancet Diabetes Endocrinol. 2015 Oct;3(10):816-25
pubmed: 26071885
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e926-e935
pubmed: 33141191
Biomed Res Int. 2022 Feb 10;2022:8447080
pubmed: 35187173
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Am J Phys Med Rehabil. 2021 Feb 1;100(2):105-109
pubmed: 33181531
Endocr Pract. 2022 May;28(5):494-501
pubmed: 35202790
Front Endocrinol (Lausanne). 2020 Oct 07;11:566439
pubmed: 33117282
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e803-e811
pubmed: 33180932
Science. 2022 Mar 11;375(6585):1122-1127
pubmed: 35271343
Pulmonology. 2021 Sep-Oct;27(5):452-455
pubmed: 33454281
Cytokine Growth Factor Rev. 2021 Apr;58:82-91
pubmed: 33573850
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778

Auteurs

Laura Croce (L)

Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Pavia, Italy.

Elisabetta Zampogna (E)

Respiratory Rehabilitation of the Institute of Tradate, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italy.

Francesca Coperchini (F)

Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Pietro Costa (P)

Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Patrizia Pignatti (P)

Allergy and Immunology Unit, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Pavia, Italy.

Dina Visca (D)

Respiratory Rehabilitation of the Institute of Tradate, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italy.
Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese, Italy.

Antonio Spanevello (A)

Respiratory Rehabilitation of the Institute of Tradate, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italy.
Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese, Italy.

Mario Rotondi (M)

Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Unit of Endocrinology and Metabolism, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH